Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens.docVIP

下载本文档

6
0
约2.2万字
约 7页
2017-05-16 发布于上海
举报
版权申诉

Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens.doc

1、本文档共7页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens

Pathogens 2012, 1, 30-36; doi:10.3390/pathogens1010030 OPEN ACCESS pathogens ISSN 2076-0817 /journal/pathogens Article Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology Specimens Isabella W. Martin 1, Heather B. Steinmetz 2, Claudine L. Lefferts 2, Larry J. Dumont 1, Laura J. Tafe 1 and Gregory J. Tsongalis 3,* 1 Department of Pathology, Dartmouth Hitchcock Medical Center and Geisel School of Medicine at Dartmouth, One Medical Center Drive, Lebanon, NH 03756, USA; E-Mails: Isabella.w.martin@ (I.W.M.); larry.j.dumont@ (L.J.D.); laura.j.tafe@ (L.J.T.) 2 Department of Pathology, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA; E-Mails: heather.b.steinmetz@ (H.B.S.); Claudine.l.lefferts@ (C.L.L.); 3 Department of Pathology, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, and Norris Cotton cancer Center, One Medical Center Drive, Lebanon, NH 03756, USA * Author to whom correspondence should be addressed; E-Mail: gregory.j.tsongalis@; Tel.: +1-603-650-5498; Fax: +1-603-650-4845. Received: 12 August 2012; in revised form: 25 August 2012 / Accepted: 31 August 2012 / Published: 12 September 2012 Abstract: As new platforms for high-risk strains of human papillomavirus (HR HPV) testing are introduced into the clinical laboratory, it is important to verify their performance and agreement. In this validation study, post-aliquot cervical cytopathology specimens (n = 226) were used to analyze agreement between the Invader HPV ASR assay (Hologic) and the recently FDA-approved Cobas 4800 high-risk HPV assay (Roche). Residual sample from 92 Invader positive and 134 Invader negative samples were analyzed with the Cobas 4800 test. Discordant results were further analyzed by Linear Array HPV genotype testing (Roche). To assess intra- and inter-run precision, 31 Invader positive samples were run in duplicate on the Cobas 4800 b